Evidence map›Paper›PMID 38265445›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2024

Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis.

Tengyu Jin, Haoyuan Wang, Yuelin Liu, Hebo Wang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tengyu JinHebei Medical University, Shijiazhuang 050011, Hebei, China.ORCID 0009-0008-9048-8930
Haoyuan WangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.ORCID 0009-0002-4926-4448
Yuelin LiuHebei Medical University, Shijiazhuang 050011, Hebei, China.
Hebo WangHebei Medical University, Shijiazhuang 050011, Hebei, China. wanghbhope@hebmu.edu.cn.ORCID 0000-0002-0598-5772

Funding

Natural Science Foundation of Hebei Province H2020307041
6 · The paper itself

Abstract

Endothelial cell (EC) dysfunction is associated with atherosclerosis. Circular RNAs (circRNAs) are covalently closed loops formed by back-splicing, are highly expressed in a tissue-specific or cell-specific manner, and regulate ECs mainly through miRNAs (mircoRNAs) or protein sponges. This review describes the regulatory mechanisms and physiological functions of circRNAs, as well as the differential expression of circRNAs in aberrant ECs. This review focuses on their roles in inflammation, proliferation, migration, angiogenesis, apoptosis, senescence, and autophagy in ECs from the perspective of signaling pathways, such as nuclear factor κB (NF-κB), nucleotide-binding domain, leucine-rich-repeat family, pyrin-domain-containing 3 (NLRP3)/caspase-1, Janus kinase/signal transducer and activator of transcription (JAK/STAT), and phosphoinositide-3 kinase/protein kinase B (PI3K/Akt). Finally, we address the issues and recent advances in circRNAs as well as circRNA-mediated regulation of ECs to improve our understanding of the molecular mechanisms underlying the progression of atherosclerosis and provide a reference for studies on circRNAs that regulate EC dysfunction and thus affect atherosclerosis.

Indexed as

AtherosclerosisMicroRNAsHumansPhosphatidylinositol 3-KinasesRNA, CircularSignal TransductionMicroRNAsPhosphatidylinositol 3-KinasesRNA, CircularAtherosclerosisCircular RNAEndothelial cellSignaling pathway

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.